Published: 3 February 2021
Author(s): Rafael Dal-Ré, Richard Stephens, Nadarajah Sreeharan
Issue: May 2021
Section: Letter to the Editor

In the first half of 2021, many millions of Europeans will be offered vaccination against SARS -CoV-2. Four vaccines, two mRNA-based vaccines (Pfizer-BioNTech and NIH-Moderna) and two non-replicating viral vector-based vaccines (Oxford-AstraZeneca and Janssen) will likely be available through national health services (NHS). Should citizens accept the vaccine provided by their NHS or should they have the option of selecting the vaccine of their choice?

Newsletters

Stay informed on our latest news!